About L2P Research Labs
L2P Research Labs is a Healthcare company based in Stony Brook (United States) founded in 2015 by Suresh Anaganti, and was acquired by NJ Bio in November 2025. L2P Research Labs is engaged in clinical and non-clinical research. It operates on a Professional Services model. Its chief executive, as recorded, is Suresh Anaganti. L2P Research Labs offers products and services including Clinical Research and Non-Clinical Research. Its focus areas include Biotechnology and Clinical Research. Its competitors include AlphaVax, DXOCRO and Cancer Research For Oza Rks.
Company details
L2P Research Labs is involved in providing clinical and non-clinical research services. The company operates in the healthcare and biotechnology sector, focusing on IND-enabling studies. State-of-the-art instruments are utilized to ensure high-quality data. Robust quality assurance programs are maintained, with GLP-compliant facilities. Solutions are offered to strengthen research outcomes for clients across various projects.
- Headquarters Stony Brook, United States
- Founders Suresh Anaganti
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website l2plabs.com
- Social LinkedIn X
- Acquired by NJ Bio (Nov 2025)
Products & Services of L2P Research Labs
L2P Research Labs offers a comprehensive portfolio of products and services, including Clinical Research and Non-Clinical Research.
Clinical research services are provided for medical studies.
Non-clinical research services are offered for preclinical studies.
Funding Insights of L2P Research Labs
- Total Rounds 1
- Last Round Grant — $319,267
- First Round $319,267
(Sep 2023)
- Investors Count 1
All 1 funding rounds of L2P Research Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $319,267 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in L2P Research Labs
L2P Research Labs has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and NJ Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Clinical development services are provided for biotechnology applications. | 2018 | njbio.com | North Brunswick, United States |
Investor details for L2P Research Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of L2P Research Labs
1 people are tracked at L2P Research Labs (1 in leadership).
| Name | Role | Group |
|---|---|---|
Suresh Anaganti | Founder & CEO | Leadership |
Complete people profiles for L2P Research Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of L2P Research Labs
3 dated milestones of L2P Research Labs across 10 years, from founding to its latest funding, stage changes and deals.
- Founded L2P Research Labs is founded.
- Funding First funding round of $319K.
- Exit Acquired by NJ Bio.
Competitors of L2P Research Labs
L2P Research Labs has 3 listed competitors in our database. They include AlphaVax, DXOCRO and Cancer Research For Oza Rks.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alphavax.com | 1997 | Durham, United States | Vaccines for infectious diseases and cancer immunotherapy are developed. | |||
| dxocro.com | 2017 | Oxford, United States | Provides in vitro diagnostic services for oncology research and development. | |||
| ozarkscancerresearch.org | 1987 | Springfield, United States | Clinical trials and research services for oncology drugs are provided. |
Detailed competitors of L2P Research Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of L2P Research Labs
The website of L2P Research Labs (l2plabs.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 50.1% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as L2P Research Labs (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about L2P Research Labs
L2P Research Labs was founded in 2015 and raised its 1st funding round 8 years after it was founded.
L2P Research Labs is headquartered in Stony Brook, United States. It is registered at Stony Brook, New York, United States.
Suresh Anaganti is the CEO of L2P Research Labs, as recorded in our data. They have also founded this company.
L2P Research Labs is involved in providing clinical and non-clinical research services. The company operates in the healthcare and biotechnology sector, focusing on IND-enabling studies. State-of-the-art instruments are utilized to ensure high-quality data. Robust quality assurance programs are maintained, with GLP-compliant facilities. Solutions are offered to strengthen research outcomes for clients across various projects.
L2P Research Labs's top competitors include AlphaVax, Cancer Research For Oza Rks and DXOCRO.
L2P Research Labs offers Clinical Research and Non-Clinical Research.
Yes. L2P Research Labs was acquired by NJ Bio in November 2025.